JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB236654

Anti-FFAR3/GPR41 antibody

1

(1 Review)

|

(9 Publications)

Rabbit Polyclonal FFAR3/GPR41 antibody. Suitable for WB and reacts with Mouse samples. Cited in 9 publications. Immunogen corresponding to Recombinant Fragment Protein within Human FFAR3 aa 250 to C-terminus.

View Alternative Names

GPR41, FFAR3, Free fatty acid receptor 3, G-protein coupled receptor 41

1 Images
Western blot - Anti-FFAR3/GPR41 antibody (AB236654)
  • WB

Supplier Data

Western blot - Anti-FFAR3/GPR41 antibody (AB236654)

All lanes:

Western blot - Anti-FFAR3/GPR41 antibody (ab236654) at 1/500 dilution

All lanes:

Mouse kidney tissue lysate

Secondary

All lanes:

Goat polyclonal to rabbit IgG at 1/10000 dilution

Predicted band size: 39 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

WB

applications

Immunogen

Recombinant Fragment Protein within Human FFAR3 aa 250 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

O14843

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/2000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Purification notes
Purity >95%.
Storage buffer
pH: 7.4 Preservative: 0.03% Proclin 300 Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Free fatty acid receptor 3 (FFAR3) also known as GPR41 is a G-protein coupled receptor. It is part of a family of receptors sensing short-chain fatty acids mainly propionate and acetate. The receptor has a mass of about 41 kDa. It is expressed mostly in intestinal tissues adipose tissue and the peripheral nervous system. FFAR3 helps in monitoring and responding to the levels of these fatty acids in various physiological contexts.
Biological function summary

FFAR3 acts as a sensor and regulator of energy balance in the body. It is not part of a large protein complex but instead directly interacts with its ligands the short-chain fatty acids to modulate signaling pathways. FFAR3 primarily influences the release of hormones like insulin and leptin contributing to metabolic homeostasis. This receptor plays a significant role in converting dietary nutrients into energy signals.

Pathways

FFAR3 integrates into the signaling control of the gut-brain axis and energy regulation. It participates actively in the cAMP signaling pathway which includes interactions with other receptors such as the FFAR2. Through these pathways it supports cellular responses essential for maintaining glucose and lipid metabolism balance. These processes are important for adapting to changes in dietary intake and ensuring homeostatic energy management.

FFAR3 associates with metabolic conditions including type 2 diabetes and hypertension. Its function in regulating insulin and energy levels links it to both of these conditions. Furthermore interaction with proteins like adenylate cyclase involved in the cAMP pathway also ties it to these diseases. Studying FFAR3 is valuable for understanding and potentially modulating metabolic disorders making it an important target for therapeutic investigations.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

G protein-coupled receptor that is activated by a major product of dietary fiber digestion, the short chain fatty acids (SCFAs), and that plays a role in the regulation of whole-body energy homeostasis and in intestinal immunity. In omnivorous mammals, the short chain fatty acids acetate, propionate and butyrate are produced primarily by the gut microbiome that metabolizes dietary fibers. SCFAs serve as a source of energy but also act as signaling molecules. That G protein-coupled receptor is probably coupled to the pertussis toxin-sensitive, G(i/o)-alpha family of G proteins. Its activation results in the formation of inositol 1,4,5-trisphosphate, the mobilization of intracellular calcium, the phosphorylation of the MAPK3/ERK1 and MAPK1/ERK2 kinases and the inhibition of intracellular cAMP accumulation (PubMed : 12711604). Activated by SCFAs and by beta-hydroxybutyrate, a ketone body produced by the liver upon starvation, it inhibits N-type calcium channels and modulates the activity of sympathetic neurons through a signaling cascade involving the beta and gamma subunits of its coupled G protein, phospholipase C and MAP kinases. Thereby, it may regulate energy expenditure through the control of the sympathetic nervous system that controls for instance heart rate. Upon activation by SCFAs accumulating in the intestine, it may also signal to the brain via neural circuits which in turn would regulate intestinal gluconeogenesis. May also control the production of hormones involved in whole-body energy homeostasis. May for instance, regulate blood pressure through renin secretion. May also regulate secretion of the PYY peptide by enteroendocrine cells and control gut motility, intestinal transit rate, and the harvesting of energy from SCFAs produced by gut microbiota. May also indirectly regulate the production of LEP/Leptin, a hormone acting on the CNS to inhibit food intake, in response to the presence of short-chain fatty acids in the intestine. Finally, may also play a role in glucose homeostasis. Besides its role in energy homeostasis, may play a role in intestinal immunity. May mediate the activation of the inflammatory and immune response by SCFAs in the gut, regulating the rapid production of chemokines and cytokines by intestinal epithelial cells. Among SCFAs, the fatty acids containing less than 6 carbons, the most potent activators are probably propionate, butyrate and pentanoate while acetate is a poor activator (PubMed : 12496283, PubMed : 12711604).
See full target information FFAR3

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Oncology research 33:1199-1215 PubMed40296906

2025

A novel Wnt/β-catenin signaling gene signature for progression and metastasis of gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jia Chen,Fei Jiang,Kaiyi Niu,Haodong Zhao,L I Li,Hongzhu Yu

Cell reports. Medicine 5:101667 PubMed39106867

2024

Ketogenic diet but not free-sugar restriction alters glucose tolerance, lipid metabolism, peripheral tissue phenotype, and gut microbiome: RCT.

Applications

Unspecified application

Species

Unspecified reactive species

Aaron Hengist,Russell G Davies,Jean-Philippe Walhin,Jariya Buniam,Lucy H Merrell,Lucy Rogers,Louise Bradshaw,Alfonso Moreno-Cabañas,Peter J Rogers,Jeff M Brunstrom,Leanne Hodson,Luc J C van Loon,Wiley Barton,Ciara O'Donovan,Fiona Crispie,Orla O'Sullivan,Paul D Cotter,Kathryn Proctor,James A Betts,Françoise Koumanov,Dylan Thompson,Javier T Gonzalez

Animal nutrition (Zhongguo xu mu shou yi xue hui) 14:213-224 PubMed37484994

2023

Maternal sodium acetate supplementation promotes lactation performance of sows and their offspring growth performance.

Applications

Unspecified application

Species

Unspecified reactive species

Yingao Qi,Tenghui Zheng,Siwang Yang,Qianzi Zhang,Baofeng Li,Xiangfang Zeng,Yongxing Zhong,Fang Chen,Wutai Guan,Shihai Zhang

British journal of pharmacology 179:4315-4329 PubMed35393660

2022

Short-chain fatty acids regulate B cells differentiation via the FFA2 receptor to alleviate rheumatoid arthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Yao Yao,Xiaoyu Cai,Yongquan Zheng,Meng Zhang,Weidong Fei,Dongli Sun,Mengdan Zhao,Yiqing Ye,Caihong Zheng

Microbiome 10:62 PubMed35430804

2022

The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids.

Applications

Unspecified application

Species

Unspecified reactive species

Weiping Xiao,Jiabin Su,Xinjie Gao,Heng Yang,Ruiyuan Weng,Wei Ni,Yuxiang Gu

Heliyon 6:e05647 PubMed33319102

2020

Morphological elucidation of short-chain fatty acid receptor GPR41-positive enteric sensory neurons in the colon of mice with dextran sulfate sodium-induced colitis.

Applications

Unspecified application

Species

Unspecified reactive species

Ai Hertati,Shusaku Hayashi,Hanako Ogata,Kana Miyata,Ryo Kato,Takeshi Yamamoto,Makoto Kadowaki

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20:2413-2424 PubMed32243709

2020

Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjiao Jiao,Zijian Zhang,Yue Xu,Lian Gong,Weixun Zhang,Hao Tang,Song Zeng,Qiang Zhang,Zhaoli Sun,Ling Liu,Xiaopeng Hu

Biochimica et biophysica acta. Molecular and cell 1865:158666 PubMed32061840

2020

Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Daisuke Mikami,Mamiko Kobayashi,Junsuke Uwada,Takashi Yazawa,Kazuko Kamiyama,Kazuhisa Nishimori,Yudai Nishikawa,Sho Nishikawa,Seiji Yokoi,Hideki Kimura,Ikuo Kimura,Takanobu Taniguchi,Masayuki Iwano

Nutrients 11: PubMed31752111

2019

Butyric Acid and Leucine Induce α-Defensin Secretion from Small Intestinal Paneth Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Akiko Takakuwa,Kiminori Nakamura,Mani Kikuchi,Rina Sugimoto,Shuya Ohira,Yuki Yokoi,Tokiyoshi Ayabe
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com